Presentations by Program

Search by Program

Discovery of a Novel Series of Penicillin-binding Protein 3 Inhibitors to Treat Pseudomonas aeruginosa Infections: Rational Design of Biochemical Potency and Bacterial Permeation

Durand-Reville T, Wu X, Guler S, Zhang J, Comita-Prevoir J, Sylvester M, Romero J, Velez-Vega C, Wu F, Iyer R, Shapiro A, Moussa S, Carter N, Chen A, McLeod S, O'Donnell J, Miller A and Tommasi R (ASM ESCMID 2019)

The Novel β-lactamase Inhibitor ETX1317 Restores the Activity of Cefpodoxime Against Drug-Resistant Enterobacteriaceae

McLeod S, Carter N, Moussa S, Mueller J, Tommasi R and Miller A (Microbe 2019)

Scientific Overview of Entasis Pipeline

Tommasi R (Microbe 2019)

Efficacy of Cefpodoxime Proxetil and ETX0282 in a Murine UTI Model with E. coli and K. pneumoniae

Weiss WJ, Carter K, Pulse ME, Nguyen P, Valtierra D, Peterson K, Tommasi R, Mueller JP, O'Donnell J (ECCMID 2019)